Viatris Inc.
VTRSNASDAQHealthcare● Active
$16.00
+$0.12(+0.75%)
Market Cap$18.6B
P/E Ratio—
52W High$17.53
52W Low$8.44
Viatris Inc. (VTRS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
VTRS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$0.59
Est. $0.50 · +17.5%
Revenue
$3.52B
Est. $3.36B · +4.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 5-Quarter EPS Beat Streak
VTRS reports quarterly as a NASDAQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.46
Rev. $3.65B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.46
Rev. Est.$3.65B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.62 | — | — | — | $3.67B | — |
| ▲ Q2 FY2026 | May 7, 2026 | $0.50 | $0.59 | +17.5% | $3.52B | $3.36B | +4.8% |
| ▲ Q1 FY2026 | Feb 26, 2026 | $0.53 | $0.57 | +7.1% | $3.70B | $3.53B | +4.8% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $0.62 | $0.67 | +7.9% | $3.76B | $3.62B | +3.8% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $0.56 | $0.62 | +11.5% | $3.58B | $3.47B | +3.3% |
| ▲ Q2 FY2025 | May 8, 2025 | $0.49 | $0.50 | +1.6% | $3.25B | $3.24B | +0.6% |
| ▼ Q1 FY2025 | Feb 27, 2025 | $0.61 | $0.54 | -11.5% | $3.53B | $3.60B | -2.0% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $0.68 | $0.75 | +10.8% | $3.74B | $3.72B | +0.6% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.62
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$0.59
EPS Est.
$0.50
EPS Surpr.
+17.5%
Revenue
$3.52B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
$0.57
EPS Est.
$0.53
EPS Surpr.
+7.1%
Revenue
$3.70B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$0.67
EPS Est.
$0.62
EPS Surpr.
+7.9%
Revenue
$3.76B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$0.62
EPS Est.
$0.56
EPS Surpr.
+11.5%
Revenue
$3.58B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$0.50
EPS Est.
$0.49
EPS Surpr.
+1.6%
Revenue
$3.25B
Q1 FY2025
Feb 27, 2025Miss
EPS Actual
$0.54
EPS Est.
$0.61
EPS Surpr.
-11.5%
Revenue
$3.53B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.75
EPS Est.
$0.68
EPS Surpr.
+10.8%
Revenue
$3.74B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.64 | $0.66 | $0.67 | 2 |
| Q3 FY2027 | $0.66 | $0.68 | $0.69 | 2 |
| Q2 FY2027 | $0.63 | $0.65 | $0.66 | 2 |
| Q1 FY2027 | $0.60 | $0.62 | $0.63 | 2 |
| Q4 FY2026 | $0.60 | $0.62 | $0.63 | 4 |
| Q3 FY2026 | $0.63 | $0.64 | $0.66 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $3.8B | $3.9B | $3.9B | 2 |
| Q3 FY2027 | $3.8B | $3.9B | $4.0B | 2 |
| Q2 FY2027 | $3.7B | $3.8B | $3.8B | 2 |
| Q1 FY2027 | $3.5B | $3.6B | $3.6B | 2 |
| Q4 FY2026 | $3.7B | $3.8B | $3.8B | 2 |
| Q3 FY2026 | $3.8B | $3.8B | $3.8B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +17.5% | $15.95 | $17.39 | +9.03% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +7.1% | $16.08 | $15.25 | -5.16% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +7.9% | $10.75 | $10.11 | -5.95% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +11.5% | $8.75 | $9.39 | +7.31% |
| ▲ Q2 FY2025 | May 8, 2025 | +1.6% | $8.60 | $9.09 | +5.70% |
| ▼ Q1 FY2025 | Feb 27, 2025 | -11.5% | $11.24 | $9.53 | -15.21% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +10.8% | $11.61 | $13.18 | +13.52% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +1.8% | $11.36 | $12.10 | +6.51% |
Q2 FY2026+9.03%
Report Date
May 7, 2026
EPS Beat/Miss
+17.5%
Price Before
$15.95
Price After
$17.39
Q1 FY2026-5.16%
Report Date
Feb 26, 2026
EPS Beat/Miss
+7.1%
Price Before
$16.08
Price After
$15.25
Q4 FY2025-5.95%
Report Date
Nov 6, 2025
EPS Beat/Miss
+7.9%
Price Before
$10.75
Price After
$10.11
Q3 FY2025+7.31%
Report Date
Aug 7, 2025
EPS Beat/Miss
+11.5%
Price Before
$8.75
Price After
$9.39
Q2 FY2025+5.70%
Report Date
May 8, 2025
EPS Beat/Miss
+1.6%
Price Before
$8.60
Price After
$9.09
Q1 FY2025-15.21%
Report Date
Feb 27, 2025
EPS Beat/Miss
-11.5%
Price Before
$11.24
Price After
$9.53
Q4 FY2024+13.52%
Report Date
Nov 7, 2024
EPS Beat/Miss
+10.8%
Price Before
$11.61
Price After
$13.18
Q3 FY2024+6.51%
Report Date
Aug 8, 2024
EPS Beat/Miss
+1.8%
Price Before
$11.36
Price After
$12.10
Avg Beat Reaction+4.42%
Avg Miss Reaction-15.21%
Beat Rate7 / 8 quarters
Largest Move-15.21% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: VTRS ends December
Viatris Inc. (VTRS) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $0.59 — beating the analyst consensus of $0.50 by +17.5%. VTRS has beaten EPS estimates for 5 consecutive quarters. The next VTRS earnings date is expected around September 1, 2026.
Each quarter, investors track VTRS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. VTRS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
VTRS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
VTRS earnings · 5 questionsViatris Inc.'s next earnings report is expected around September 1, 2026. VTRS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; VTRS historically reports after market close (AMC).
VTRS earnings datewhen is VTRS earningsVTRS next earnings datewhen does VTRS report earningsVTRS earnings calendar
▸ Source: FMP · Viatris Inc. SEC filings · US GAAP · Viatris Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026